Role of CRT on PR interval in patients with LV dysfunction.

  • Research type

    Research Study

  • Full title

    Functional remodelling of Atrioventricular node in patients with LV dysfunction after Cardiac resynchronization therapy

  • IRAS ID

    137216

  • Contact name

    Clifford Garratt

  • Contact email

    clifford.garratt@cmft.nhs.uk

  • Sponsor organisation

    Central Manchester University Hospital NHS foundation trust

  • Research summary

    This project aims to study the role of Cardiac resynchronization therapy in the remodelling of the atrioventricular (AV) node in heart failure patients. AV node is the specialized part of the heart’s specialized conduction system.
    The heart beat is initiated and coordinated by this specialized conduction system of heart. An artificial pacemaker has to be fitted, if with disease or old age, these specialised parts of the heart, function inappropriately. The dysfunction of the AV node is commonly called heart block. Heart block can potentially result in blackouts and/or death in the affected individuals if not treated with an artificial pacemaker. Heart block occurs when there is a problem in the conduction of the electrical impulse through the atrioventricular node (AV node). Heart block is commonly seen with old age and in patients with heart failure. Patients with heart failure receive a special pacemaker to improve their symptoms. This special pacemaker is called biventricular pacemaker or cardiac resynchronization therapy (CRT). CRT has been shown to provide better benefit in patients with heart blocks suggesting possible remodelling of the AV node after CRT implantation.
    To understand what goes wrong and devise new treatments for heart blocks, we will need further research to improve our understanding of this specialised part of the conduction system of the heart. This study will improve our understanding of potential mechanisms of AV node remodelling which can be used in future research to identify mechanisms that can be used to cure heart blocks. It could also result in closer follow-up of patients with heart blocks, which may result in decreased hospital admission and/or mortality. At present the only treatment of the heart block is insertion of an artificial pacemaker, which in itself is associated with different complications.

  • REC name

    Yorkshire & The Humber - South Yorkshire Research Ethics Committee

  • REC reference

    13/YH/0398

  • Date of REC Opinion

    3 Jan 2014

  • REC opinion

    Further Information Favourable Opinion